Approval · Notice of Compliance 4605 · 1996
OXYCONTIN: Notice of Compliance 4605
Issued January 4, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4605
- Date
- January 4, 1996
- Company
- Purdue Frederick
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Opioid analgesic